TANG KEVIN

AUPH

TANG KEVIN serves as Director at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$37.13M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$37.13M

Companies Traded

AUPH

Active Period

Dec 2024 – Aug 2025

3 total trades

Most Recent

Buy AUPH

Aug 1, 2025 · $13.59M

TANG KEVIN's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

3 · $37.13M

Sells

0 · $0.00

Total Shares Bought

4,100,000

Total Shares Sold

AUPH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Aug 1, 2025↗	Buy	1,300,000	$10.45	$13.59M
Feb 28, 2025↗	Buy	1,600,000	$7.95	$12.71M
Dec 5, 2024↗	Buy	1,200,000	$9.02	$10.82M

Related Insiders

Joseph M Miller

Chief Financial Officer

AUPHSell · Feb 20, 2026

Peter Greenleaf

Chief Executive Officer

AUPHSell · Feb 20, 2026

Matthew Maxwell Donley

Chief Operating Officer

AUPHSell · Feb 20, 2026

Stephen P. Robertson

EVP, General Counsel

AUPHSell · Feb 20, 2026

Greg Keenan

SVP, Chief Medical Officer

AUPHSell · Feb 2, 2026

Jeffrey Allen Bailey

Director

AUPHSell · Nov 21, 2025

Craig A Johnson

Director

AUPHSell · Nov 21, 2025

Greg Keenan

Chief Medical Officer

AUPHSell · Aug 1, 2025

Explore More Insider Trading Data

AUPH Insider Trading Activity

View all insider trades at Aurinia Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity